[go: up one dir, main page]

AU2001237484A1 - Use of trimetazidine to inhibit acyl-coa acetyl transferase - Google Patents

Use of trimetazidine to inhibit acyl-coa acetyl transferase

Info

Publication number
AU2001237484A1
AU2001237484A1 AU2001237484A AU3748401A AU2001237484A1 AU 2001237484 A1 AU2001237484 A1 AU 2001237484A1 AU 2001237484 A AU2001237484 A AU 2001237484A AU 3748401 A AU3748401 A AU 3748401A AU 2001237484 A1 AU2001237484 A1 AU 2001237484A1
Authority
AU
Australia
Prior art keywords
trimetazidine
acetyl transferase
coa acetyl
inhibit acyl
acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001237484A
Other languages
English (en)
Inventor
Gary Lopaschuk
Arnaud Lucien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of AU2001237484A1 publication Critical patent/AU2001237484A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001237484A 2000-02-25 2001-02-23 Use of trimetazidine to inhibit acyl-coa acetyl transferase Abandoned AU2001237484A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0002385A FR2805463B1 (fr) 2000-02-25 2000-02-25 UTILISATION DE LA TRIMETAZIDINE POUR L'OBTENTION DE COMPOSITIONS PHARMACEUTIQUES DESTINEES A INHIBER L'ACYL-CoA ACETYLTRANSFERASE
FR0002385 2000-02-25
PCT/FR2001/000535 WO2001064220A1 (fr) 2000-02-25 2001-02-23 UTILISATION DE TRIMETAZIDINE POUR INHIBER L'ACYL-CoA ACETYLTRANSFERASE

Publications (1)

Publication Number Publication Date
AU2001237484A1 true AU2001237484A1 (en) 2001-09-12

Family

ID=8847399

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001237484A Abandoned AU2001237484A1 (en) 2000-02-25 2001-02-23 Use of trimetazidine to inhibit acyl-coa acetyl transferase

Country Status (3)

Country Link
AU (1) AU2001237484A1 (fr)
FR (1) FR2805463B1 (fr)
WO (1) WO2001064220A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
US8822473B2 (en) 2002-05-21 2014-09-02 Gilead Sciences, Inc. Method of treating diabetes
US20040063717A1 (en) 2002-05-21 2004-04-01 Andrew Wolff Method of treating diabetes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3262852A (en) * 1966-07-26 Vasodilator and anti-anginose com- pounds containing methoxy benzyl piperazines and method of using the same
FR805M (fr) * 1960-06-30 1961-09-01
FR2490963B1 (fr) * 1980-09-30 1986-04-18 Science Union & Cie Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine
FR2681324B1 (fr) * 1991-09-18 1993-10-29 Adir Cie Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant.
AUPN380695A0 (en) * 1995-06-23 1995-07-20 Queen Elizabeth Hospital, The Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions

Also Published As

Publication number Publication date
WO2001064220A1 (fr) 2001-09-07
FR2805463A1 (fr) 2001-08-31
FR2805463B1 (fr) 2003-01-24

Similar Documents

Publication Publication Date Title
AU2002213248A1 (en) Synthesis of epothilones and relates analogs
AU2001253863A1 (en) Design of viscoelastic coatings to reduce turbulent friction drag
AU2001243158A1 (en) Inhibitors of prenyl-protein transferase
AU2002353180A1 (en) Use of ugt inhibitors to increase bioavailability
AU2001238217A1 (en) Inhibitors of prenyl-protein transferase
AU2001247197A1 (en) Inhibitors of prenyl-protein transferase
AU2001282147A1 (en) Enzymatic synthesis of antioxidant hydroxytyrosol
AU2001227757A1 (en) Inhibitors of prenyl-protein transferase
AU2001238424A1 (en) Inhibitors of prenyl-protein transferase
AU2001237484A1 (en) Use of trimetazidine to inhibit acyl-coa acetyl transferase
AU2002219175A1 (en) Crystalline forms of cerivastatin sodium
AU2001245741A1 (en) Antisense inhibition of adam10 expression
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof
GB0029847D0 (en) Preparation of spheroids
AU2001229320A1 (en) Inhibitors of prenyl-protein transferase
AU2001254754A1 (en) Use of alkoxy esters
AU2001227756A1 (en) Inhibitors of prenyl-protein transferase
AU2001234461A1 (en) Antisense modulation of daxx expression
AU2001253601A1 (en) 5-substituted tetralones as inhibitors of ras farnesyl transferase
AU2001288908A1 (en) Antisense modulation of mekk3 expression
AU2001245950A1 (en) Preparation of deoxynucleosides
AU2001251445A1 (en) Inhibitors of prenyl-protein transferase
AU2001227755A1 (en) Inhibitors of prenyl-protein transferase
AU2001273010A1 (en) Inhibitors of prenyl-protein transferase
AU2001290588A1 (en) Inhibitors of prenyl-protein transferase